One year ago, heading into the U.S. Thanksgiving holiday, biotech was on a roll with public biotech companies developing therapeutics setting a record pace and BioWorld's Blue Chip Index up a whopping 76 percent in value, considerably outpacing the general markets, with the Dow Jones Industrial average up 22 percent and the Nasdaq Composite index up 33 percent over the same period. Read More
